Clinical Trials on New-onset type1 Diabetes in Austria

Total 694 results

Medical University of Vienna

Terminated

Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation (ISINODAT)

New Onset Diabetes Mellitus After Renal Transplantation

Austria
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Completed

Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)

Type 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes Mellitus

United States, Australia
Idorsia Pharmaceuticals Ltd.

Completed

Tezosentan in Acute Heart Failure (VERITAS 1)

Acute Heart Failure | Acute Decompensation of Chronic Heart Failure | New Onset of Heart Failure

United States, United Kingdom, Israel, Switzerland, Austria, Denmark, France, Germany, Greece, Poland
Idorsia Pharmaceuticals Ltd.

Completed

Tezosentan in the Treatment of Acute Heart Failure (VERITAS 2)

Acute Heart Failure | Acute Decompensation of Chronic Heart Failure | New Onset of Heart Failure

United States, Hungary, Australia, Czechia, Germany, Italy, Norway, United Kingdom
University of Graz
Medical University of Graz

Recruiting

Maternal ExeRcIse Timing to Optimise Postprandial Glucose in Type 1 Diabetes (MERIT1D)

Type 1 Diabetes | Pregnancy in Diabetic

Austria
Medical University of Vienna

Unknown

Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients

Type2 Diabetes Mellitus

Austria
Metronom Health
Medical University of Graz

Unknown

Metronom Continuous Glucose Monitoring System

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabete Mellitus

Austria, Denmark
Medical University of Vienna

Terminated

Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM)

Diabetes Mellitus, Type 1 | Diabetic Retinopathy

Austria
Medical University of Vienna

Completed

The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp

Diabetes Mellitus, Type 1 | Insulin | Retina | Regional Blood Flow

Austria
Medical University of Vienna
AstraZeneca

Completed

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. (EXENDA)

Type2 Diabetes | Steatosis, Liver

Austria
Medical University of Graz

Completed

Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes (PROLOG)

Healthy | Obesity | Type 2 Diabetes Mellitus | Type 1 Diabetes

Austria
Landeskrankenhaus Feldkirch

Completed

Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study

Diabetic Peripheral Neuropathy | Diabetes Mellitus Type I | Nerve Conduction Study Not Performed

Austria
Landsteiner Institut
Lund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaborators

Completed

Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes (RECO2)

Type 2 Diabetes Mellitus | Insulin Resistance

Austria
University of Adelaide
Salk Institute for Biological Studies; University of South Australia

Completed

Time RestrIcted Feeding For Improving Diabetes Risk (TRIFFID) (TRIFFID)

Obesity | Type2 Diabetes

Australia
Medical University of Vienna
Attoquant Diagnostics

Completed

EMPRA (EMPagliflozin and RAs in Kidney Disease) (EMPRA)

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3

Austria
Capillary Biomedical, Inc.

Terminated

SteadiSet™ Pilot Study (SteP Study)

Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDM

Austria
Mesoblast, Ltd.

Completed

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Diabetic Nephropathy | Type 2 Diabetes

Australia
Landsteiner Institut
Medical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaborators

Completed

Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans (RECO1)

Type 2 Diabetes Mellitus

Austria
Paracelsus Medical University

Completed

Secondary Prevention in Type 2 Diabetes: Comparison of Two Different Resistance Exercise Training Protocols

Type 2 Diabetes Mellitus

Austria
Ionis Pharmaceuticals, Inc.

Completed

Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes

Type 2 Diabetes

Austria
University of Vienna

Unknown

Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB) (MIKRODIAB)

Cancer | Type 2 Diabetes

Austria
MetaCure Limited

Unknown

The DIAMOND® for the Treatment of Type 2 Diabetes

Type 2 Diabetes

Australia, Austria, Greece, Italy, Poland, Serbia
Medical University of Vienna

Completed

The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes (HYPOTESIS)

Type 2 Diabetes

Austria
Medical University of Vienna

Completed

Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects

Type I Diabetes

Austria
Medical University of Graz

Completed

EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes

Austria
Medical University of Graz
Medical University of Vienna

Completed

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

Type 1 Diabetes

Austria
Medical University of Graz
Menarini Group

Completed

Performance Study to Test the GlucoMen®Day System Using Intravascular and Subcutaneous Microdialysis in Subjects With Type 1 Diabetes

Type 1 Diabetes

Austria
CeQur Corporation
International Diabetes Center at Park Nicollet

Completed

Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Medical University of Graz

Completed

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

Hyperglycemia | Diabetes Mellitus Type 2

Austria
Alexandra Kautzky-Willer
Bayer

Recruiting

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism (Test2Func)

Fatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes Mellitus

Austria
Medical University of Graz

Completed

Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards

Type 2 Diabetes

Austria
Medical University of Graz

Completed

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management

Type 2 Diabetes

Austria
Medical University of Graz

Completed

Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders (CARDIONOR)

Diabetes Mellitus, Type II

Austria
CeQur Corporation

Terminated

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Medical University of Graz
European Commission

Completed

Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

Type 1 Diabetes

Austria
Medical University of Vienna

Completed

Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin (LixiBIT)

Type 2 Diabetes Mellitus

Austria
CeQur Corporation

Completed

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Medical University of Vienna

Completed

Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements

Diabetes Mellitus Type II

Austria
Medical University of Graz

Completed

Incretin Effect on the Immunological Phenotype

Type 1 Diabetes

Austria
Medical University of Vienna

Unknown

Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects

Type 2 Diabetes Mellitus | Endothelial Dysfunction | Cardiovascular Risk

Austria
German Diabetes Center

Completed

Phielix et al.: Hepatic Fat Content and Adipokines

Type 2 Diabetes Mellitus

Austria
Medical University of Vienna

Unknown

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations (RISC_7T)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Healthy Volunteers | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Familiar Hypocalcuric Hypercalcemia

Austria
AstraZeneca
Takeda

Completed

Diabetic Retinopathy Candesartan Trials (DIRECT)

Type 1 Diabetes

Denmark, Australia
Medical University of Vienna
National Bank of Austria

Unknown

Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus (Tele-Diab)

Insulin Resistance | Diabetes Mellitus Type 2

Austria
Medical University of Graz
Menarini Group

Completed

Accuracy, Reliability and Safety of GlucoMen®Day, a New Generation Microdialysis Continuous Glucose Monitor

Type 1 Diabetes

Austria
Landsteiner Institut
University of Coimbra

Completed

Non Invasive Assessment of Liver Glycogen Kinetics and ATP Synthesis in Type1 Diabetics

Type 1 Diabetes Mellitus

Austria
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)

Diabetes Mellitus, Type 2 | Diabetes

Austria
Landeskrankenhaus Feldkirch

Completed

Nerve Conduction Velocity in Diabetic Children

Type 1 Diabetes Mellitus

Austria
Hoffmann-La Roche

Completed

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Type 2 Diabetes, Type 1 Diabetes

Austria, United Kingdom
Texas Cardiac Arrhythmia Research Foundation

Recruiting

Natural History of COVID-19-Related Atrial Fibrillation (unCOVer-AF)

COVID-19 | Atrial Fibrillation New Onset

Italy, United States, Belgium

Clinical Trials on New-onset type1 Diabetes in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations